跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CARDIVASC - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
CARDIVASC
Approved
STANDARD
CARDIVASC
E.L. Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
66a86b4577f8f2b2
Company
E.L. Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
66a86b4577f8f2b2
Drug Approval Philippines Name
CARDIVASC
Product Name
CARDIVASC
Registration Number
DR-XY36005
Brand Name
CARDIVASC
Generic Name
Amlodipine (as besilate)
Dosage Form
Tablet
Dosage Strength
5 mg
Manufacturer
E.L. Laboratories, Inc.
Trader
The Cathay YSS Distributors Company, Incorporated
Distributor
The Cathay YSS Distributors Company, Incorporated
Issuance Date
25 January 2024
Expiry Date
19 June 2029
Pharmacologic Category
Calcium Channel Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
66a86b4577f8f2b2
Type
Standard
Back to Philippines FDA Approvals